Combined genetic polymorphism and risk for development of lung cancer

Randa El-Zein, Joseph B. Zwischenberger, Thomas Wood, Sherif Abdel-Rahman, Chad Brekelbaum, William W. Au

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Susceptibility to lung cancer has been shown to be modulated by host specific factors. Inheritance of different polymorphic cytochrome P450s (CYPs) and the glutathione S-transferases (GSTs) which affect metabolism of environmental toxicants may play a key role in individual susceptibility. Although individual polymorphic genes have been reported to be associated with development of lung cancer, little is known about the combined effects of several genes in carcinogenesis. From our study of 54 lung cancer patients and 50 matched controls, we observed that a combination of several versions of 'unfavorable' metabolizing genes (CYP2D6, CYP2E1, GSTM1 and GSTT1) is strongly associated with lung cancer. The relative risk for the different combinations of these genotypes ranged between 1.3 and 14, with higher risk involving the activating genes. The duration and intensity of heavy smoking (expressed in pack-years) are the most important determinant for the development of lung cancer. For example, the estimated risk for development of lung cancer associated with smoking > 30 pack-years is represented by an odds ratio = 6.65 95% CL = 2.3-19.9 irrespective of an individual's genotype, whereas for smoking between > 30 and < 50 pack-years, odds ratio = 4.5; 95% CL = 1.37-15; and for smoking > 50 pack-years, odds ratio = 30; 95% CL = 5.7- 114. On the other hand, smoking of less than 30 pack-years is associated with an increased risk in the presence of the polymorphic genes (odds ratio = 2.5; 95% CL = 0.32-54). The results of our study indicate that the inheritance of multiple unfavorable genotypes, especially activating genes, is a crucial a predisposing factor for the development of lung cancer from cigarette smoking. In addition, the genes may cause moderate smokers who would normally outlive the deleterious effects of smoking to develop lung cancer. The information can therefore be used to target individuals for prevention of health problems.

Original languageEnglish (US)
Pages (from-to)189-200
Number of pages12
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume381
Issue number2
DOIs
StatePublished - Nov 28 1997

Fingerprint

Genetic Polymorphisms
Lung Neoplasms
Smoking
Genes
Odds Ratio
Genotype
Cytochrome P-450 CYP2E1
Cytochrome P-450 CYP2D6
Cytochromes
Glutathione Transferase
Causality
Carcinogenesis
Health

Keywords

  • Cigarette smoking
  • CYP2D6
  • CYP2E1
  • Genetic polymorphism
  • GSTM1
  • GSTT1
  • Lung cancer
  • Molecular epidemiology

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

Combined genetic polymorphism and risk for development of lung cancer. / El-Zein, Randa; Zwischenberger, Joseph B.; Wood, Thomas; Abdel-Rahman, Sherif; Brekelbaum, Chad; Au, William W.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 381, No. 2, 28.11.1997, p. 189-200.

Research output: Contribution to journalArticle

El-Zein, Randa ; Zwischenberger, Joseph B. ; Wood, Thomas ; Abdel-Rahman, Sherif ; Brekelbaum, Chad ; Au, William W. / Combined genetic polymorphism and risk for development of lung cancer. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 1997 ; Vol. 381, No. 2. pp. 189-200.
@article{494ed2a48efa4eb3bb4f0ad9656caa79,
title = "Combined genetic polymorphism and risk for development of lung cancer",
abstract = "Susceptibility to lung cancer has been shown to be modulated by host specific factors. Inheritance of different polymorphic cytochrome P450s (CYPs) and the glutathione S-transferases (GSTs) which affect metabolism of environmental toxicants may play a key role in individual susceptibility. Although individual polymorphic genes have been reported to be associated with development of lung cancer, little is known about the combined effects of several genes in carcinogenesis. From our study of 54 lung cancer patients and 50 matched controls, we observed that a combination of several versions of 'unfavorable' metabolizing genes (CYP2D6, CYP2E1, GSTM1 and GSTT1) is strongly associated with lung cancer. The relative risk for the different combinations of these genotypes ranged between 1.3 and 14, with higher risk involving the activating genes. The duration and intensity of heavy smoking (expressed in pack-years) are the most important determinant for the development of lung cancer. For example, the estimated risk for development of lung cancer associated with smoking > 30 pack-years is represented by an odds ratio = 6.65 95{\%} CL = 2.3-19.9 irrespective of an individual's genotype, whereas for smoking between > 30 and < 50 pack-years, odds ratio = 4.5; 95{\%} CL = 1.37-15; and for smoking > 50 pack-years, odds ratio = 30; 95{\%} CL = 5.7- 114. On the other hand, smoking of less than 30 pack-years is associated with an increased risk in the presence of the polymorphic genes (odds ratio = 2.5; 95{\%} CL = 0.32-54). The results of our study indicate that the inheritance of multiple unfavorable genotypes, especially activating genes, is a crucial a predisposing factor for the development of lung cancer from cigarette smoking. In addition, the genes may cause moderate smokers who would normally outlive the deleterious effects of smoking to develop lung cancer. The information can therefore be used to target individuals for prevention of health problems.",
keywords = "Cigarette smoking, CYP2D6, CYP2E1, Genetic polymorphism, GSTM1, GSTT1, Lung cancer, Molecular epidemiology",
author = "Randa El-Zein and Zwischenberger, {Joseph B.} and Thomas Wood and Sherif Abdel-Rahman and Chad Brekelbaum and Au, {William W.}",
year = "1997",
month = "11",
day = "28",
doi = "10.1016/S0027-5107(97)00166-8",
language = "English (US)",
volume = "381",
pages = "189--200",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Combined genetic polymorphism and risk for development of lung cancer

AU - El-Zein, Randa

AU - Zwischenberger, Joseph B.

AU - Wood, Thomas

AU - Abdel-Rahman, Sherif

AU - Brekelbaum, Chad

AU - Au, William W.

PY - 1997/11/28

Y1 - 1997/11/28

N2 - Susceptibility to lung cancer has been shown to be modulated by host specific factors. Inheritance of different polymorphic cytochrome P450s (CYPs) and the glutathione S-transferases (GSTs) which affect metabolism of environmental toxicants may play a key role in individual susceptibility. Although individual polymorphic genes have been reported to be associated with development of lung cancer, little is known about the combined effects of several genes in carcinogenesis. From our study of 54 lung cancer patients and 50 matched controls, we observed that a combination of several versions of 'unfavorable' metabolizing genes (CYP2D6, CYP2E1, GSTM1 and GSTT1) is strongly associated with lung cancer. The relative risk for the different combinations of these genotypes ranged between 1.3 and 14, with higher risk involving the activating genes. The duration and intensity of heavy smoking (expressed in pack-years) are the most important determinant for the development of lung cancer. For example, the estimated risk for development of lung cancer associated with smoking > 30 pack-years is represented by an odds ratio = 6.65 95% CL = 2.3-19.9 irrespective of an individual's genotype, whereas for smoking between > 30 and < 50 pack-years, odds ratio = 4.5; 95% CL = 1.37-15; and for smoking > 50 pack-years, odds ratio = 30; 95% CL = 5.7- 114. On the other hand, smoking of less than 30 pack-years is associated with an increased risk in the presence of the polymorphic genes (odds ratio = 2.5; 95% CL = 0.32-54). The results of our study indicate that the inheritance of multiple unfavorable genotypes, especially activating genes, is a crucial a predisposing factor for the development of lung cancer from cigarette smoking. In addition, the genes may cause moderate smokers who would normally outlive the deleterious effects of smoking to develop lung cancer. The information can therefore be used to target individuals for prevention of health problems.

AB - Susceptibility to lung cancer has been shown to be modulated by host specific factors. Inheritance of different polymorphic cytochrome P450s (CYPs) and the glutathione S-transferases (GSTs) which affect metabolism of environmental toxicants may play a key role in individual susceptibility. Although individual polymorphic genes have been reported to be associated with development of lung cancer, little is known about the combined effects of several genes in carcinogenesis. From our study of 54 lung cancer patients and 50 matched controls, we observed that a combination of several versions of 'unfavorable' metabolizing genes (CYP2D6, CYP2E1, GSTM1 and GSTT1) is strongly associated with lung cancer. The relative risk for the different combinations of these genotypes ranged between 1.3 and 14, with higher risk involving the activating genes. The duration and intensity of heavy smoking (expressed in pack-years) are the most important determinant for the development of lung cancer. For example, the estimated risk for development of lung cancer associated with smoking > 30 pack-years is represented by an odds ratio = 6.65 95% CL = 2.3-19.9 irrespective of an individual's genotype, whereas for smoking between > 30 and < 50 pack-years, odds ratio = 4.5; 95% CL = 1.37-15; and for smoking > 50 pack-years, odds ratio = 30; 95% CL = 5.7- 114. On the other hand, smoking of less than 30 pack-years is associated with an increased risk in the presence of the polymorphic genes (odds ratio = 2.5; 95% CL = 0.32-54). The results of our study indicate that the inheritance of multiple unfavorable genotypes, especially activating genes, is a crucial a predisposing factor for the development of lung cancer from cigarette smoking. In addition, the genes may cause moderate smokers who would normally outlive the deleterious effects of smoking to develop lung cancer. The information can therefore be used to target individuals for prevention of health problems.

KW - Cigarette smoking

KW - CYP2D6

KW - CYP2E1

KW - Genetic polymorphism

KW - GSTM1

KW - GSTT1

KW - Lung cancer

KW - Molecular epidemiology

UR - http://www.scopus.com/inward/record.url?scp=0031589736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031589736&partnerID=8YFLogxK

U2 - 10.1016/S0027-5107(97)00166-8

DO - 10.1016/S0027-5107(97)00166-8

M3 - Article

VL - 381

SP - 189

EP - 200

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 2

ER -